Insights

Perspective, tips, and resources for moving health forward

All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
AmerisourceBergen

What manufacturers need to know about reimbursement and patient support for cell and gene therapies

Ana Stojanovska; Myra Reinhardt
July 2021

Manufacturers

Navigating the payer landscape for digital therapeutics

Lash Group
June 2021

Manufacturers

Patient support for digital therapeutics: Do's and don'ts for designing your program

Lash Group
June 2021

Manufacturers

Digital therapeutics: Critical elements for building effective patient support programs

Lash Group
June 2021

Manufacturers

Work worth doing: Innovative field solutions

Melissa Mulchahey
Xcenda
June 2021

Manufacturers

Work worth doing: FormularyDecisions

Laurie Fazio
Xcenda
May 2021

Manufacturers

What manufacturers need to know about annual reverification

Lash Group
May 2021

Manufacturers

eBook: Making an impact on medication adherence

AmerisourceBergen
May 2021

Manufacturers

The essential guide to drug commercialization

AmerisourceBergen
May 2021

Manufacturers

Podcast: ThinkLive Commercialization 2021

tommy bramley lash group
Tommy Bramley, PhD; Matt Sarnes, PharmD; Brian Ansay
Lash Group
May 2021

Manufacturers

On-demand webinar: Success factors for commercializing rare disease and orphan drugs

AmerisourceBergen
April 2021
Commercializing rare and orphan disease products

Manufacturers

What is a digital companion, and how is it changing patient support for the better?

AmerisourceBergen
April 2021

Manufacturers

On-demand webinar: Accelerating access to therapy (a view from the front lines)

AmerisourceBergen
April 2021
Accelerating access to therapy

Manufacturers

Case study: Improving medication adherence with a digital companion

Lash Group
April 2021

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

AmerisourceBergen
April 2021

Manufacturers

Post-launch checklist: What to look for in a commercialization partner

AmerisourceBergen
April 2021
Post-launch checklist

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

AmerisourceBergen
April 2021
Strategic partnerships for unlocking product potential ebook

Manufacturers

Drug development checklist: What to look for in a commercialization partner

AmerisourceBergen
April 2021
Clinical Development Checklist

Manufacturers

Five questions to ask a potential patient support partner

Lash Group
April 2021

Manufacturers

The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2

Innomar Strategies
April 2021

Manufacturers

On-demand webinar: The power of data across your product journey

AmerisourceBergen
March 2021
The power of data across your product journey

Manufacturers

Harnessing the power of a digital assistant to accelerate patient access

Lash Group
March 2021

Manufacturers

On demand webinar: Considerations for the commercialization of cell and gene therapies

AmerisourceBergen
March 2021
Considerations for the commercialization of cell and gene therapies

Manufacturers

How to make the most of integrated commercialization solutions

Glen Martin
AmerisourceBergen
March 2021
AmerisourceBergen manufacturer commercialization strategies

Manufacturers

Buy-and-bill vs. self-administered: Field services remove barriers across access points

Rod Bryant
Rod Bryant, MS; MarSha Lewers
March 2021

Manufacturers

Strategies for addressing copay accumulators: What manufacturers need to know

Corey Ford
Corey Ford, MHA; Dale Hanna
Xcenda
March 2021

Manufacturers

Pharma in the field: Barrett's story

Xcenda
March 2021

Manufacturers

Pre-launch checklist: What to look for in a commercialization partner

AmerisourceBergen
February 2021

Manufacturers

Checklist: Four things to look for in a field services partner

Xcenda
February 2021
xcenda field services working on project

Manufacturers

How to maximize your drug commercialization investments

AmerisourceBergen
February 2021
How to maximize your drug commercialization investments

Manufacturers

Launching field services in the midst of COVID-19

Melissa Mulchahey
Xcenda
February 2021

Manufacturers

Pharma in the field: Heather's story

Xcenda
December 2020
Doctor talking to patient

Manufacturers

Cell and gene therapies: bringing innovation to market

AmerisourceBergen
December 2020
Lab tech with DNA

Manufacturers

Webinar: the growing utilization of copay accumulator programs

Corey Ford
Corey Ford, MHA; Dale Hanna
Xcenda
December 2020
lash group copay accumulator program

Manufacturers

Pharma in the field: Ashley's story

Xcenda
November 2020
Doctor talking to patient

Manufacturers

Pharma in the field: Tierra's story

Xcenda
November 2020

Manufacturers

Ebook: Virtual drug commercialization

AmerisourceBergen
November 2020

Manufacturers

The road to a COVID-19 treatment launch

AmerisourceBergen
October 2020

Manufacturers

PAP 2020 panel recap: Navigating COVID-19

AmerisourceBergen
October 2020
blue face masks on yellow background tiled

Manufacturers

Five growth drivers for the consumer healthcare products market

Jessica Donati
Strategic Global Sourcing at AmerisourceBergen
October 2020
consumer scanning products on smartphone in store

Manufacturers

Is your PIE incomplete?

Xcenda
September 2020

Manufacturers

Rethink field services: Three myths keeping access barriers in front of your product

Melissa Mulchahey
Xcenda
August 2020
female_doctor_virtual_visit

Manufacturers

What a unified approach to business excellence means for patient support program success

Bill Smith lash group
Bill Smith
Lash Group
August 2020

Manufacturers

Pharma in the field: Sales reps vs. reimbursement and access specialists

Xcenda
July 2020

Manufacturers

The Future of Payer Engagement: How Pharma Can Break Through

Matt Sarnes, PharmD; Allen Lising
June 2020

Manufacturers

The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving

AmerisourceBergen icon
Bre Penzner; Nancy Young
Xcenda
May 2020

Manufacturers

Webinar Part 2: Leveraging AI within eBV to speed access to therapy

Shanna Barnes; Myra Reinhardt
Lash Group
May 2020

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

Bryan Horveath
Bryan Horveath, MS
May 2020

Manufacturers

Webinar: Patient Assistance in the Wake of COVID19

Lash Group
May 2020

Manufacturers

Simplifying the Path to Better Patient Outcomes

tommy bramley lash group
Tommy Bramley, PhD
Lash Group
May 2020

Manufacturers

Commercializing in Canada: Quality Assurance and GMP Services

Innomar Strategies
April 2020

Manufacturers

Commercializing in Canada: Regulatory Publishing and Submissions

Innomar Strategies
April 2020

Manufacturers

Building Partnerships and Scaling Services to Patient Needs

Shanna Barnes
Lash Group
April 2020
Six people at a conference table

Manufacturers

A Patient-Centric Approach to Technology and Analytics

Myra Reinhardt lash group
Myra Reinhardt
Lash Group
March 2020
lightbulb w patient DNA strand

Data Analytics Enables Program Improvements for Faster Access to Therapy

Lash Group
March 2020
Access_to_therapy

Manufacturers

Physician Q&A: How to Boost Confidence in Biosimilars

Kashyap Patel, MD
Carolina Blood and Cancer Care
February 2020

Manufacturers

Video: Removing Barriers for Biosimilars

AmerisourceBergen
February 2020

Manufacturers

Mind the (Evidence) Gap

Kim McLeod
Kim McLeod, MPH
Xcenda
February 2020

Manufacturers

Nurse Stories: Jessica

Lash Group
January 2020

Manufacturers

Case study: real-world benefits of an oncology navigation program

Lash Group
January 2020

Manufacturers

White paper: beyond the promise of artificial intelligence in electronic benefit verification

Lash Group
January 2020

The future of eBV is here. How manufacturers can use AI to help patients start life-changing therapies faster than ever.

Manufacturers

Infographic: Physician Perspectives on Biosimilars

AmerisourceBergen
December 2019

Manufacturers

InnomarLive 2019: Commercializing in Canada

Innomar Strategies
December 2019

E-book: Delivering Innovation, Improving Lives

AmerisourceBergen
December 2019

Manufacturers

Nurse Stories: Amy

Lash Group
November 2019

How do nurses make a difference when it comes to patient-centric adherence programs? A Lash Group nurse shares how she offers personal support for rare disease patients.

Manufacturers

How to Launch a Patient Support Program

Todd Wells lash group
Todd Wells
Lash Group
November 2019

Executive Q&A: best practices for a patient support program launch.

Manufacturers

How Patient Support Program Nurses Help Break Down Adherence Barriers

Lash Group
November 2019

Lash Group's nurse educators offer empathy, experience and expertise to help patients navigate the complexities of today's specialty therapies. Learn how they add critical value to adherence programs.

Manufacturers

Biosimilars: Market Insights and Growth Factors

Sean McGowan; Rick Lozano
AmerisourceBergen
September 2019

The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.

Manufacturers

Biosimilars: Launch Insights From the Field

Melissa Mulchahey
Xcenda
September 2019

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

Manufacturers

Biosimilars: Shaping a Moving Market

AmerisourceBergen
September 2019

An animated, immersive biosimilar market snapshot with actionable insight for manufacturers.

Manufacturers

Case Study: Improving Speed to Therapy With Provider Portals

Lash Group
August 2019

Innovative therapies make innovative patient services essential. Learn how Lash Group helped one manufacturer improve speed and access to therapy with an electronic provider portal for benefit verification and prior authorization.

Manufacturers

Uncommon Commonalities: A Patient-Centric Strategy for Improving Medication Adherence

Dale Hanna
Lash Group
August 2019

What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

Xcenda
July 2019

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Manufacturers

How Tech-Enabled Solutions Impact Adherence

tommy bramley lash group
Tommy Bramley, PhD
Lash Group
May 2019

Executive Q&A: The market trends and technology solutions impacting medication adherence today.

Manufacturers

Managing the Growing Expansion of Copay Accumulators

Corey Ford
Corey Ford, MHA
Xcenda
March 2019

Manufacturers

The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part Two

Ann Pham, Director, Business Development, ICS
Ann Pham
September 2018

How can FTZs help with commercialization success? What should manufacturers consider when evaluating a FTZ and 3PL partner?

Manufacturers

The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part One

Ann Pham, Director, Business Development, ICS
Ann Pham
September 2018

What are FTZs and why should pharma use them?

Manufacturers

The Supply Chain Redefined: Cell and Gene Therapies

AmerisourceBergen
July 2018

Much of the complexity of the cell and gene supply chain comes from how dependent the commercialization phase is on the clinical phase. What does integration look like, and how can the right logistics partner help?

Manufacturers

Financial Management for Cell and Gene Therapies

Albert Cooksey, Senior Vice President and General Manager, 3PL Services, ICS
Albert Cooksey
July 2018

How third-party logistics (3PL) solutions can help cell and gene therapy manufacturers manage the financial aspects of launching new therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Ana Stojanovska
June 2018

An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Ana Stojanovska
June 2018

An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.

Manufacturers

Rethink: Channel Strategy for Oral Oncolytics

AmerisourceBergen
May 2018

How manufacturers can benefit from provider-led care coordination to improve patient outcomes.

Infographic: The Road to Commercialization in Canada

AmerisourceBergen
May 2018

Manufacturers

A New Approach to Channel Strategy for Oncology Therapies

AmerisourceBergen
April 2018

How is manufacturer thinking around channel strategy changing for oral oncolytics?

Manufacturers

Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

AmerisourceBergen
April 2018
Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Manufacturers

Rethinking Reimbursement and Patient Support Following Medical Innovation

AmerisourceBergen
January 2018

How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?

Manufacturers

Information Exchange With Payers and Providers

AmerisourceBergen
January 2018

What information do payers and providers want from pharma?

Manufacturers

The Growth of Biosimilars in the Oncology Pipeline

Dave Picard; Brian Ansay
AmerisourceBergen
September 2017

What should biosimilar manufacturers focus on for commercialization success?

Manufacturers

Rethink: The Future of Benefit Verification

AmerisourceBergen
September 2017

What does the future of benefit verification look like for manufacturer patient support programs?

Manufacturers

Logistics Decisions Will Impact the Success of New Cell and Gene Therapies

AmerisourceBergen
July 2017

In supply chain decisions, a wholly new type of product demands a wholly new definition for supply chain expertise and effective support.

Manufacturers

Commercializing Cell and Gene Therapies

AmerisourceBergen
July 2017

Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.

Manufacturers

Changing Channels

Donna Gilbert
AmerisourceBergen
April 2017

Learn the unintended consequences of channel strategy decisions and the impact on patients and providers.

Manufacturers

The Fundamentals of Commercialization Strategy

AmerisourceBergen
February 2015

Successful commercialization demands that manufacturers address three critical areas of opportunity — evidence, access and adherence.